Answers are grounded in this paper and cite their sources.
MRI is becoming the imaging modality of choice in patients with ischemic cerebrovascular disease although CT is still the test of choice to exclude acute hemorrhagic stroke. We have briefly reviewed characteristic features of ischemic and hemorrhagic cerebrovascular disease as well as vascular anomalies as seen on MRI. In time MRS should provide useful noninvasive metabolic data to complement the anatomical data in patients with cerebrovascular disease.
No takes yet. Share an insight, caveat, or question.
Ramadan et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: